{"nct_id":"NCT00328198","title":"Subcutaneous Alemtuzumab (CAMPATH®, MabCampath®) in Relapsed/Refractory B-Cell Chronic Lymphocytic Leukemia","status":"COMPLETED","status_verified_date":"2014-02","start_date":"2006-05","start_date_type":null,"primary_completion_date":"2011-08","primary_completion_date_type":"ACTUAL","completion_date":"2011-08","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["SNY"]}